A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids

Free Radical Biology and Medicine

Volumn 47, Issue 2, 2009, Pages 145-151

  Lee, Sangderk ^a   Gharavi, Nima M ^a   Honda, Henry ^a   Chang, Irene ^a   Kim, Brandon ^a   Jen, Nelson ^a   Li, Rongsong ^a   Zimman, Alejandro ^a   Berliner, Judith A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Endothelium; Free radicals; NOX4; Ox PAPC; Reactive oxygen species; VEGFR2

Indexed keywords

INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED 1 PALMITOYL 2 ARACHIDONYL SN GLYCEROL 3 PHOSPHORYLCHOLINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE; PROTEIN P22; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; STEROL SYNTHESIS; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM;

CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; NADPH OXIDASE; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINES; RAC1 GTP-BINDING PROTEIN; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 67349208391     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.04.013     Document Type: Article

References (43)

1. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., and Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84 (1989) 1086-1095
2. Subbanagounder G., Leitinger N., Schwenke D.C., Wong J.W., Lee H., Rizza C., Watson A.D., Faull K.F., Fogelman A.M., and Berliner J.A. Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2248-2254
3. Gargalovic P.S., Imura M., Zhang B., Gharavi N.M., Clark M.J., Pagnon J., Yang W.P., He A., Truong A., Patel S., Nelson S.F., Horvath S., Berliner J.A., Kirchgessner T.G., and Lusis A.J. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc. Natl. Acad. Sci. USA 103 (2006) 12741-12746
4. Gharavi N.M., Gargalovic P.S., Chang I., Araujo J.A., Clark M.J., Szeto W.L., Watson A.D., Lusis A.J., and Berliner J.A. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1346-1353
5. Berliner J.A., and Gharavi N.M. Endothelial cell regulation by phospholipid oxidation products. Free Radic. Biol. Med. 45 (2008) 119-123
6. Zimman A., Mouillesseaux K.P., Le T., Gharavi N.M., Ryvkin A., Graeber T.G., Chen T.T., Watson A.D., and Berliner J.A. Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 332-338
7. Rouhanizadeh M., Hwang J., Clempus R.E., Marcu L., Lassegue B., Sevanian A., and Hsiai T.K. Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase. Free Radic. Biol. Med. 39 (2005) 1512-1522
8. Bedard K., and Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007) 245-313
9. Chen K., Thomas S.R., and Keaney Jr. J.F. Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic. Biol. Med. 35 (2003) 117-132
10. Gharavi N.M., Baker N.A., Mouillesseaux K.P., Yeung W., Honda H.M., Hsieh X., Yeh M., Smart E.J., and Berliner J.A. Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids. Circ. Res. 98 (2006) 768-776
11. Babior B.M., Lambeth J.D., and Nauseef W. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397 (2002) 342-344
12. Nauseef W.M. Assembly of the phagocyte NADPH oxidase. Histochem. Cell Biol. 122 (2004) 277-291
13. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol., Regul. Integr. Comp. Physiol. 285 (2003) R277-297
14. Van Buul J.D., Fernandez-Borja M., Anthony E.C., and Hordijk P.L. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid. Redox Signal. 7 (2005) 308-317
15. Grasberger H., and Refetoff S. Identification of the maturation factor for dual oxidase: evolution of an eukaryotic operon equivalent. J. Biol. Chem. 281 (2006) 18269-18272
16. Ambasta R.K., Kumar P., Griendling K.K., Schmidt H.H., Busse R., and Brandes R.P. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 279 (2004) 45935-45941
17. Gorin Y., Ricono J.M., Kim N.H., Bhandari B., Choudhury G.G., and Abboud H.E. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am. J. Physiol., Renal Physiol. 285 (2003) F219-229
18. Kuroda J., Nakagawa K., Yamasaki T., Nakamura K., Takeya R., Kuribayashi F., Imajoh-Ohmi S., Igarashi K., Shibata Y., Sueishi K., and Sumimoto H. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10 (2005) 1139-1151
19. Subbanagounder G., Wong J.W., Lee H., Faull K.F., Miller E., Witztum J.L., and Berliner J.A. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis: formation of these oxidized phospholipids in response to interleukin-1beta. J. Biol. Chem. 277 (2002) 7271-7281
20. Lee H., Shi W., Tontonoz P., Wang S., Subbanagounder G., Hedrick C.C., Hama S., Borromeo C., Evans R.M., Berliner J.A., and Nagy L. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ. Res. 87 (2000) 516-521
21. Navab M., Hough G.P., Stevenson L.W., Drinkwater D.C., Laks H., and Fogelman A.M. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J. Clin. Invest. 82 (1988) 1853-1863
22. Li R., Chen W., Yanes R., Lee S., and Berliner J.A. OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids. J. Lipid Res. 48 (2007) 709-715
23. Reinehr R., Sommerfeld A., Keitel V., Grether-Beck S., and Haussinger D. Amplification of CD95 activation by caspase 8-induced endosomal acidification in rat hepatocytes. J. Biol. Chem. 283 (2008) 2211-2222
24. Yalcin S., Zhang X., Luciano J.P., Mungamuri S.K., Marinkovic D., Vercherat C., Sarkar A., Grisotto M., Taneja R., and Ghaffari S. Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J. Biol. Chem. 283 (2008) 25692-25705
25. Meissner F., Molawi K., and Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat. Immunol. 9 (2008) 866-872
26. Fortuno A., San Jose G., Moreno M.U., Diez J., and Zalba G. Oxidative stress and vascular remodelling. Exp. Physiol. 90 (2005) 457-462
27. Hwang J., Ing M.H., Salazar A., Lassegue B., Griendling K., Navab M., Sevanian A., and Hsiai T.K. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ. Res. 93 (2003) 1225-1232
28. Pedruzzi E., Guichard C., Ollivier V., Driss F., Fay M., Prunet C., Marie J.C., Pouzet C., Samadi M., Elbim C., O'Dowd Y., Bens M., Vandewalle A., Gougerot-Pocidalo M.A., Lizard G., and Ogier-Denis E. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 24 (2004) 10703-10717
29. Wingler K., Wunsch S., Kreutz R., Rothermund L., Paul M., and Schmidt H.H. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31 (2001) 1456-1464
30. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24 (2003) 471-478
31. Quinn M.T., and Bokoch G.M. Measurement of Rac translocation from cytosol to membranes in activated neutrophils. Methods Enzymol. 256 (1995) 256-267
32. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
33. Ushio-Fukai M. VEGF signaling through NADPH oxidase-derived ROS. Antioxid. Redox Signal. 9 (2007) 731-739
34. Ushio-Fukai M., Tang Y., Fukai T., Dikalov S.I., Ma Y., Fujimoto M., Quinn M.T., Pagano P.J., Johnson C., and Alexander R.W. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 91 (2002) 1160-1167
35. Holmes K., Roberts O.L., Thomas A.M., and Cross M.J. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell. Signal. 19 (2007) 2003-2012
36. Yamaoka-Tojo M., Ushio-Fukai M., Hilenski L., Dikalov S.I., Chen Y.E., Tojo T., Fukai T., Fujimoto M., Patrushev N.A., Wang N., Kontos C.D., Bloom G.S., and Alexander R.W. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ. Res. 95 (2004) 276-283
37. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., and Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91 (2002) 406-413
38. Vejrazka M., Micek R., and Stipek S. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim. Biophys. Acta 1722 (2005) 143-147
39. Riganti C., Costamagna C., Bosia A., and Ghigo D. The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress. Toxicol. Appl. Pharmacol. 212 (2006) 179-187
40. Mattevi A. To be or not to be an oxidase: challenging the oxygen reactivity of flavoenzymes. Trends Biochem. Sci. 31 (2006) 276-283
41. Chakraborty S., and Massey V. Reaction of reduced flavins and flavoproteins with diphenyliodonium chloride. J. Biol. Chem. 277 (2002) 41507-41516
42. Walton K.A., Gugiu B.G., Thomas M., Basseri R.J., Eliav D.R., Salomon R.G., and Berliner J.A.A. role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J. Lipid Res. 47 (2006) 1967-1974
43. Lee S., Li R., Kim B., Palvolgyi R., Ho T., Yang Q.Z., Xu J., Szeto W.L., Honda H., and Berliner J.A. Ox-PAPC activation of PMET system increases expression of heme oxygenase 1 in human aortic endothelial cell. J. Lipid Res. 50 (2009) 265-274